KRT19 antibody

Ref. 3D-10R-4565

Informations sur le produit

• Nom: KRT19 antibody
• Marque: Biosynth
• Description: The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug classified under rifamycins. It is specifically designed to treat tuberculosis infections by targeting the active compounds in bacteria and exerting bactericidal activity. This drug works by binding to DNA-dependent RNA polymerase, effectively preventing transcription and replication, inhibiting bacterial growth. Its high efficacy has been demonstrated through extensive research using the patch-clamp technique on human erythrocytes. Moreover, it undergoes various metabolic transformations such as hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. Additionally, it exhibits specific binding to markers expressed at high levels in Mycobacterium tuberculosis strains, effectively inhibiting their growth in culture. With its multifaceted mechanism of action and targeted approach, 6-Fluoro